【22年8月】神经科上个月最受关注SCI论文解析

其他

2022-08-10 03:08

Knowledge is power.

Bringing medical advances from the lab to the clinic.

关键词：神经科；重点论文；

(图源：medicoverhospitals)

做科研、尤其是选题，需要读很多文献；最高效的阅读方式是，先读领域内最受关注的论文。

我们通过大数据分析，找到了神经科及关联疾病在2022年7月发表的论文中，最受关注的论文；希望对同仁们快速了解围绕着神经科最新进展有帮助。

如需全文，可加科研助手申请递送，并提供文章编号（仅限3天）。

1，临床前阿尔茨海默病生物标志物可准确预测认知和神经病理学结果

Long JM, et al. Preclinical Alzheimer's disease biomarkers accurately predict cognitive and neuropathological outcomes. Brain. 2022 Jul 22:awac250. doi: 10.1093/brain/awac250. Epub ahead of print. PMID: 35867858.

获取全文请加科研助手，标注“20220810-1”。

2，单纯血栓切除术与静脉阿替普酶联合血栓切除术治疗卒中患者：一项开放标签、盲法、随机非劣效性试验

Fischer U, et al. Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke: an open-label, blinded-outcome, randomised non-inferiority trial. Lancet. 2022 Jul 9;400(10346):104-115. doi: 10.1016/S0140-6736(22)00537-2. PMID: 35810756.

获取全文请加科研助手，标注“20220810-2”。

3，重新审视 HLA-DRB1 与吸烟在帕金森病中的相互作用

Domenighetti C, et al. The Interaction between HLA-DRB1 and Smoking in Parkinson's Disease Revisited. Mov Disord. 2022 Jul 10. doi: 10.1002/mds.29133. Epub ahead of print. PMID: 35810454.

获取全文请加科研助手，标注“20220810-3”。

4，亨廷顿病的生物学分类：综合分期系统

Tabrizi SJ, et al. A biological classification of Huntington's disease: the Integrated Staging System. Lancet Neurol. 2022 Jul;21(7):632-644. doi: 10.1016/S1474-4422(22)00120-X. PMID: 35716693.

获取全文请加科研助手，标注“20220810-4”。

5，从多发性硬化前驱期到疾病预防

Marrie RA, et al. From the prodromal stage of multiple sclerosis to disease prevention. Nat Rev Neurol. 2022 Jul 15. doi: 10.1038/s41582-022-00686-x. Epub ahead of print. PMID: 35840705.

获取全文请加科研助手，标注“20220810-5”。

6，表观遗传基因和癫痫 - 新兴机制和临床应用

Van Loo KMJ, et al. Epigenetic genes and epilepsy - emerging mechanisms and clinical applications. Nat Rev Neurol. 2022 Jul 20. doi: 10.1038/s41582-022-00693-y. Epub ahead of print. PMID: 35859062.

获取全文请加科研助手，标注“20220810-6”。

7，药物-基因相互作用的药物基因组学检测对重度抑郁症药物选择和症状缓解的影响：PRIME Care 随机临床试验

Oslin DW, et al. Effect of Pharmacogenomic Testing for Drug-Gene Interactions on Medication Selection and Remission of Symptoms in Major Depressive Disorder: The PRIME Care Randomized Clinical Trial. JAMA. 2022 Jul 12;328(2):151-161. doi: 10.1001/jama.2022.9805. PMID: 35819423; PMCID: PMC9277497.

获取全文请加科研助手，标注“20220810-7”。

8，参与缺血性卒中的信号通路：分子机制和治疗干预

Qin C, et al. Signaling pathways involved in ischemic stroke: molecular mechanisms and therapeutic interventions. Signal Transduct Target Ther. 2022 Jul 6;7(1):215. doi: 10.1038/s41392-022-01064-1. PMID: 35794095; PMCID: PMC9259607.